Repetitive Magnetic Stimulation (rTMS) in Parkinson's disease

Repetitive Magnetic Stimulation (rTMS) in Parkinson's disease - rTMS PD

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00022358

Enrollment

Registered

2020-07-02

Start date

2020-12-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Group 1: rTMS real Treatment once a day, for 8 days Group 2: rTMS sham treatment

Eligibility

Sex/Gender

All

Age

40 Years to 85 Years

Inclusion criteria

Inclusion criteria: Parkinson's disease

Exclusion criteria

Exclusion criteria: PSP, MSA

Design outcomes

Primary

Measure	Time frame
improvement of postural instability at the end of Treatment (V1) and follow-up 4 weeks (V2) later using PosturoMed in comparison to baseline (V0)	—

Secondary

Measure	Time frame
improvement of UPDRS III (Unified Parkinson's Disease Rating Scale) at the end of Treatment (V1) and follow-up 4 weeks (V2) later using PosturoMed in comparison to baseline (V0)	—

Countries

Germany

Contacts

Public ContactOliver Kaut

UKB

oliver.kaut@ukbonn.de022828714431

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026